CClinicalTrials.gg
CompletedNCT05071469Updated Dec 21, 2022

Comparison of Two Different Treatment Methods

An interventional study of Kinesiotaping and Mulligan Mobilization Technique in Subacromial Impingement Syndrome, Musculoskeletal Diseases and Musculoskeletal Injury, sponsored by Banu BAYAR. Completed at 1 site in Turkey. Open to participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-12-21.

Sponsored by Banu BAYAR · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
35 Years to 65 Years
Sex
All
01

Study summary

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Read the detailed description

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

02

Conditions studied

  • Subacromial Impingement Syndrome
  • Musculoskeletal Diseases
  • Musculoskeletal Injury
  • Musculoskeletal Pain
  • Weakness, Muscle

Keywords

  • Subacromial Impingement Syndrome
  • Mulligan Mobilization Technique
  • Kinesiotaping
  • Physiotherapy
03

In context

Musculoskeletal Pain

493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.

This study's enrollment of 60 is below the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.

Browse Musculoskeletal Pain studies →

Lead sponsor

Banu BAYAR is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Impingement symptoms in clinical tests
  • Pain >1 month

Exclusion criteria

Exclusion Criteria:

  • Any shoulder pathology.
  • Have chronic systemic diseases or infections.
  • History of any surgery shoulder complex.
  • steroid injections and therapeutic approaches
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    Control Group (CG)

    Control group

  • Experimental
    Kinesiotaping Group (KG)

    Experimental group

    Other: Kinesiotaping

  • Experimental
    Mulligan Mobilization Technique Group (MG)

    Experimental group (2)

    Other: Mulligan Mobilization Technique

Interventions

  • OtherKinesiotaping

    KT was applied.

  • OtherMulligan Mobilization Technique

    MMT was applied

06

What researchers measure

Primary outcomes

  1. Change of pain severity

    Via VAS.

    Time frame: Baseline- after 2 weeks (after treatment)

  2. Change of Range of Motion

    Via goniometer.

    Time frame: Baseline- after 2 weeks (after treatment)

  3. Change of Functionality

    Via SPADI.

    Time frame: Baseline- after 2 weeks (after treatment)

Secondary outcomes

  1. Change of Sleep Quality

    Via VAS.

    Time frame: Baseline- after 2 weeks (after treatment)

  2. Change of Satisfaction of Life

    Via SWLS.

    Time frame: Baseline- after 2 weeks (after treatment)

  3. Change of Satisfaction of Treatment

    Via VAs.

    Time frame: Baseline- after 2 weeks (after treatment)

07

Study locations

1 site
  • Muğla Sıtkı Koçman University
    Muğla, 48000, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05071469
Lead sponsor
Banu BAYAR
Collaborators
Muğla Sıtkı Koçman University
Responsible party
Banu BAYAR (Principal investigator, Head of Physiotherapy and Rehabilitation Department, Pt. PhD. Prof., Muğla Sıtkı Koçman University) — Sponsor-investigator
First posted
Oct 8, 2021
Start date
Sep 28, 2021
Primary completion
Oct 15, 2021
Completion
Nov 30, 2021
Last update
Dec 21, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion